Metabolite information |
|
HMDB ID | HMDB0000929 |
Synonyms |
(-)-Tryptophan(2S)-2-amino-3-(1H-indol-3-yl)Propanoate(2S)-2-amino-3-(1H-indol-3-yl)Propanoic acid(L)-Tryptophan(S)-1H-Indole-3-alanine(S)-2-amino-3-(3-Indolyl)propionic acid(S)-Tryptophan(S)-a-Aminoindole-3-propionate(S)-a-Aminoindole-3-propionic acid(S)-a-amino-1H-Indole-3-propanoate(S)-a-amino-1H-Indole-3-propanoic acid(S)-a-amino-b-(3-Indolyl)-propionate(S)-a-amino-b-(3-Indolyl)-propionic acid(S)-a-amino-b-Indolepropionate(S)-a-amino-b-Indolepropionic acid(S)-alpha-Aminoindole-3-propionate(S)-alpha-Aminoindole-3-propionic acid(S)-alpha-amino-1H-Indole-3-propanoate(S)-alpha-amino-1H-Indole-3-propanoic acid(S)-alpha-amino-beta-(3-Indolyl)-propionate(S)-alpha-amino-beta-(3-Indolyl)-propionic acid(S)-alpha-amino-beta-Indolepropionate(S)-alpha-amino-beta-Indolepropionic acid(S)-α-amino-1H-indole-3-propanoate(S)-α-amino-1H-indole-3-propanoic acid(S)-α-amino-β-(3-indolyl)-propionate(S)-α-amino-β-(3-indolyl)-propionic acid1-beta-3-Indolylalanine1H-Indole-3-alanine1beta-3-Indolylalanine2-amino-3-Indolylpropanoate2-amino-3-Indolylpropanoic acid3-(1H-indol-3-yl)-L-Alanine3-indol-3-YlalanineAlpha'-amino-3-indolepropionic acidArdeydormArdeypharm brand OF tryptophanArdeytropinEsparma brand OF tryptophanH-TRP-OHICN brand OF tryptophanIndole-3-alanineKalmaKalma brand OF tryptophanL TryptophanL Tryptophan ratiopharmL-(-)-TryptophanL-TryptofanL-Tryptophan-ratiopharmL-TryptophaneL-alpha-Aminoindole-3-propionic acidL-alpha-amino-3-Indolepropionic acidL-b-3-IndolylalanineL-beta-3-IndolylalanineL-β-3-indolylalanineLevotryptophanLopac-T-0254LyphanMerck brand OF tryptophanNaturruheNiddapharm brand OF tryptophanOptimaxPMS TryptophanPMS-TryptophanPacitronPharmascience brand OF tryptophanRatiopharm brand OF tryptophanSedanoctTriptofanoTrofanTrpTryptacinTryptanTryptophanTryptophan metabolism alterationsTryptophaneTryptophanumUpsher-smith brand OF tryptophanWalpha-Aminoindole-3-propionic acidratio Tryptophanratio-Tryptophan |
Chemical formula | C11H12N2O2 |
IUPAC name | (2S)-2-amino-3-(1H-indol-3-yl)propanoic acid |
CAS registry number | 73-22-3 |
Monoisotopic molecular weight | 204.089877638 |
Chemical taxonomy |
|
Super class | Organoheterocyclic compounds |
Class | Indoles and derivatives |
Sub class | Indolyl carboxylic acids and derivatives |
Biological properties |
|
Pathways (Pathway Details in HMDB) |
|
Reference | Country | Specimen | Marker function | Participants (Case) | Participants (Control) | |||||||||
Cancer type | Stage | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | Type | Number | Gender (M,F) | Age mean (range) (M/F) | Smoking status | ||||
Hori et al. 2011 | Japan | tissue | diagnosis | adenocarcinoma, squamous cell carcinoma, SCLC | – | 7 | 6, 1 | median: 61 (53-82) | smoker, non-smoker | tumor vs. adjacent normal tissue | 7 | 6, 1 | median: 61 (53-82) | smoker, non-smoker |
Qi et al. 2021 | China | blood | diagnosis | adenocarcinoma, squamous cell carcinoma, small cell lung cancer, other types, unknown types | I, II, III, IV | 98 | 51, 47 | Median: 50 (32-69) | – | healthy | 75 | 36, 39 | Median: 50 (31-69) | – |
Kowalczyk et al. 2021 | Poland | Tissue | diagnosis | adenocarcinoma (ADC) | I, II, III | 33 | 23, 10 | 64.77 ± 8.44 | – | healthy control | 20 | 13, 7 | 61.5 ± 12.06 | – |
Kowalczyk et al. 2021 | Poland | Tissue | diagnosis | squemous cell carcinoma (SCC) | I, II, III | 54 | 39, 15 | 64.45 ± 8.02 | – | healthy control | 20 | 13, 7 | 61.5 ± 12.06 | – |
Reference | Chromatography | Ion source | Positive/Negative mode | Mass analyzer | Identification level |
Hori et al. 2011 | GC | – | – | – | – |
Qi et al. 2021 | LC | ESI | both | Q-Orbitrap | MS/MS |
Kowalczyk et al. 2021 | LC | ESI | both | Q-TOF | – |
Kowalczyk et al. 2021 | LC | ESI | both | Q-TOF | – |
Reference | Data processing software | Database search |
Hori et al. 2011 | Shimadzu GCMSsolution software | commercially available GC/MS Metabolite Mass Spectral Database (Shimadzu Co.), NIST Mass Spectral Library (NIST 08) |
Qi et al. 2021 | ProteoWizard, XCMS, Xcalibur, CAMERA | mzCloud, ChemSpider, LipidBlast and Fiehn HILIC |
Kowalczyk et al. 2021 | Mass Hunter Qualitative Analysis Software, Mass Profiler Professional | METLIN, KEGG, LIPIDMAPS, and HMDB |
Kowalczyk et al. 2021 | Mass Hunter Qualitative Analysis Software, Mass Profiler Professional | METLIN, KEGG, LIPIDMAPS, and HMDB |
Reference | Difference method | Mean concentration (case) | Mean concentration (control) | Fold change (case/control) | P-value | FDR | VIP |
Hori et al. 2011 | student’s t-test, PLS-DA | – | – | 4.43 | 0.02 | – | – |
Qi et al. 2021 | PCA, OPLS-DA, Student’s t test | – | – | 0.92 | 0.01 | – | 4.29 |
Kowalczyk et al. 2021 | Mann–Whitney U-test and Benjamini–Hochberg false discovery rate, partial least squares discriminant analysis (PLS-DA) | – | – | – | 2.25e-06 | – | – |
Kowalczyk et al. 2021 | Mann–Whitney U-test and Benjamini–Hochberg false discovery rate, partial least squares discriminant analysis (PLS-DA) | – | – | – | 2.92e-06 | – | – |
Reference | Classification method | Cutoff value | AUROC 95%CI | Sensitivity (%) | Specificity (%) | Accuracy (%) |
Hori et al. 2011 | – | – | – | – | – | – |
Qi et al. 2021 | – | – | – | – | – | – |
Kowalczyk et al. 2021 | – | – | – | – | – | – |
Kowalczyk et al. 2021 | – | – | – | – | – | – |